Cytotoxic potential of ketonucleosides

Area of Science:

• Biochemistry
• Cell Biology
• Medicinal Chemistry

Background:

• Ketonucleosides are a class of compounds with potential therapeutic applications.
• Understanding structure-activity relationships is crucial for drug development.

Purpose of the Study:

• To investigate the relationship between ketonucleoside structure and cytotoxicity in Friend leukemia cells (FLC).
• To determine how specific structural modifications affect ketonucleoside potency.

Main Methods:

• Cytotoxicity assays were performed on Friend leukemia cells (FLC) exposed to various ketonucleoside compounds.
• Cells were treated with modified ketonucleosides (KN-35, KN-3) and compared to an unsubstituted control (KN-43).
• Pre-treatment and drug-free medium incubation experiments were conducted to assess drug incorporation and persistence.

Main Results:

• Ketonucleoside KN-35, with an electrophilic agent (Br-) on the sugar moiety, showed a tenfold increase in cytotoxicity compared to KN-43.
• Ketonucleoside KN-3, with an O-acetyl group, exhibited a threefold reduction in cytotoxicity.
• Pre-treatment with KN-35 resulted in 50% inhibitory dose (ID50) in 3 minutes, versus 240 minutes for KN-43.
• Reduced cytotoxicity was observed when drugs were pre-incubated in serum-free medium.

Conclusions:

• The cytotoxic activity of ketonucleosides is strongly influenced by structural modifications.
• Electrophilic substitution enhances, while acetylation diminishes, ketonucleoside cytotoxicity.
• Drug incorporation rate appears to be a critical factor determining ketonucleoside activity in FLC.